Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Density of tumor-associated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma.

Qing W, Fang WY, Ye L, Shen LY, Zhang XF, Fei XC, Chen X, Wang WQ, Li XY, Xiao JC, Ning G.

Thyroid. 2012 Sep;22(9):905-10. doi: 10.1089/thy.2011.0452. Epub 2012 Aug 7.

2.

Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling.

Coniglio SJ, Eugenin E, Dobrenis K, Stanley ER, West BL, Symons MH, Segall JE.

Mol Med. 2012 May 9;18:519-27. doi: 10.2119/molmed.2011.00217.

3.

Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation.

Chakravarty D, Santos E, Ryder M, Knauf JA, Liao XH, West BL, Bollag G, Kolesnick R, Thin TH, Rosen N, Zanzonico P, Larson SM, Refetoff S, Ghossein R, Fagin JA.

J Clin Invest. 2011 Dec;121(12):4700-11. doi: 10.1172/JCI46382. Epub 2011 Nov 21.

4.

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.

DeNardo DG, Brennan DJ, Rexhepaj E, Ruffell B, Shiao SL, Madden SF, Gallagher WM, Wadhwani N, Keil SD, Junaid SA, Rugo HS, Hwang ES, Jirström K, West BL, Coussens LM.

Cancer Discov. 2011 Jun;1(1):54-67. doi: 10.1158/2159-8274.CD-10-0028. Epub 2011 Jun 1.

5.

Chemokine (C-C motif) ligand 2 mediates direct and indirect fibrotic responses in human and murine cultured fibrocytes.

Ekert JE, Murray LA, Das AM, Sheng H, Giles-Komar J, Rycyzyn MA.

Fibrogenesis Tissue Repair. 2011 Oct 19;4(1):23. doi: 10.1186/1755-1536-4-23.

6.

Deficiency of the macrophage growth factor CSF-1 disrupts pancreatic neuroendocrine tumor development.

Pyonteck SM, Gadea BB, Wang HW, Gocheva V, Hunter KE, Tang LH, Joyce JA.

Oncogene. 2012 Mar 15;31(11):1459-67. doi: 10.1038/onc.2011.337. Epub 2011 Aug 8.

PMID:
21822305
7.

Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma.

Caillou B, Talbot M, Weyemi U, Pioche-Durieu C, Al Ghuzlan A, Bidart JM, Chouaib S, Schlumberger M, Dupuy C.

PLoS One. 2011;6(7):e22567. doi: 10.1371/journal.pone.0022567. Epub 2011 Jul 21.

8.

CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.

Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA, Pollard JW.

Nature. 2011 Jun 8;475(7355):222-5. doi: 10.1038/nature10138.

9.

Mutationally activated BRAF(V600E) elicits papillary thyroid cancer in the adult mouse.

Charles RP, Iezza G, Amendola E, Dankort D, McMahon M.

Cancer Res. 2011 Jun 1;71(11):3863-71. doi: 10.1158/0008-5472.CAN-10-4463. Epub 2011 Apr 21.

10.

Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling.

Knauf JA, Sartor MA, Medvedovic M, Lundsmith E, Ryder M, Salzano M, Nikiforov YE, Giordano TJ, Ghossein RA, Fagin JA.

Oncogene. 2011 Jul 14;30(28):3153-62. doi: 10.1038/onc.2011.44. Epub 2011 Mar 7.

11.

Thyrotrophin receptor signaling dependence of Braf-induced thyroid tumor initiation in mice.

Franco AT, Malaguarnera R, Refetoff S, Liao XH, Lundsmith E, Kimura S, Pritchard C, Marais R, Davies TF, Weinstein LS, Chen M, Rosen N, Ghossein R, Knauf JA, Fagin JA.

Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1615-20. doi: 10.1073/pnas.1015557108. Epub 2011 Jan 10.

12.

Tumor-associated macrophages and survival in classic Hodgkin's lymphoma.

Steidl C, Lee T, Shah SP, Farinha P, Han G, Nayar T, Delaney A, Jones SJ, Iqbal J, Weisenburger DD, Bast MA, Rosenwald A, Muller-Hermelink HK, Rimsza LM, Campo E, Delabie J, Braziel RM, Cook JR, Tubbs RR, Jaffe ES, Lenz G, Connors JM, Staudt LM, Chan WC, Gascoyne RD.

N Engl J Med. 2010 Mar 11;362(10):875-85. doi: 10.1056/NEJMoa0905680.

13.

Inflammatory monocytes facilitate adaptive CD4 T cell responses during respiratory fungal infection.

Hohl TM, Rivera A, Lipuma L, Gallegos A, Shi C, Mack M, Pamer EG.

Cell Host Microbe. 2009 Nov 19;6(5):470-81. doi: 10.1016/j.chom.2009.10.007.

14.

Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis.

Karlmark KR, Weiskirchen R, Zimmermann HW, Gassler N, Ginhoux F, Weber C, Merad M, Luedde T, Trautwein C, Tacke F.

Hepatology. 2009 Jul;50(1):261-74. doi: 10.1002/hep.22950.

PMID:
19554540
15.

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.

Ricarte-Filho JC, Ryder M, Chitale DA, Rivera M, Heguy A, Ladanyi M, Janakiraman M, Solit D, Knauf JA, Tuttle RM, Ghossein RA, Fagin JA.

Cancer Res. 2009 Jun 1;69(11):4885-93. doi: 10.1158/0008-5472.CAN-09-0727.

16.

Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer.

Ryder M, Ghossein RA, Ricarte-Filho JC, Knauf JA, Fagin JA.

Endocr Relat Cancer. 2008 Dec;15(4):1069-74. doi: 10.1677/ERC-08-0036. Epub 2008 Aug 21.

17.

BRAF(V600E) mutation and outcome of patients with papillary thyroid carcinoma: a 15-year median follow-up study.

Elisei R, Ugolini C, Viola D, Lupi C, Biagini A, Giannini R, Romei C, Miccoli P, Pinchera A, Basolo F.

J Clin Endocrinol Metab. 2008 Oct;93(10):3943-9. doi: 10.1210/jc.2008-0607. Epub 2008 Aug 5.

PMID:
18682506
18.

Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells.

Oguma K, Oshima H, Aoki M, Uchio R, Naka K, Nakamura S, Hirao A, Saya H, Taketo MM, Oshima M.

EMBO J. 2008 Jun 18;27(12):1671-81. doi: 10.1038/emboj.2008.105. Epub 2008 May 29.

19.

Stromal gene expression predicts clinical outcome in breast cancer.

Finak G, Bertos N, Pepin F, Sadekova S, Souleimanova M, Zhao H, Chen H, Omeroglu G, Meterissian S, Omeroglu A, Hallett M, Park M.

Nat Med. 2008 May;14(5):518-27. doi: 10.1038/nm1764. Epub 2008 Apr 27.

PMID:
18438415
20.

Plasticity in tumor-promoting inflammation: impairment of macrophage recruitment evokes a compensatory neutrophil response.

Pahler JC, Tazzyman S, Erez N, Chen YY, Murdoch C, Nozawa H, Lewis CE, Hanahan D.

Neoplasia. 2008 Apr;10(4):329-40.

Supplemental Content

Support Center